The serum profile of adipokines in naïve patients with diabetes mellitus type 2 and obesity

Journal of Clinical Laboratory Analysis

Volumn 25, Issue 6, 2011, Pages 409-413

  de Luis, D A ^a   Aller, R ^a   Izaola, O ^a   Ovalle, H F ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adipokines; Cardiovascular risk factors; Diabetes mellitus type 2; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 6; LEPTIN; RESISTIN;

ADULT; ARTICLE; BIOCHEMISTRY; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; DEPENDENT VARIABLE; DIETARY INTAKE; FEMALE; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; OBESITY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADIPOKINES; ADIPONECTIN; ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; OBESITY; RESISTIN; RISK FACTORS;

EID: 81255178544     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20493     Document Type: Article

References (27)

1. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-919.
2. Meier U, Gressner AM. Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chem 2004;50:1511-1525.
3. Adult Treatment Panel III. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. J Am Med Assoc 2001;285:2486-2497.
4. Matsuda M, Shimomura I, Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002;277:37487-37491.
5. de Luis DA, Gonzalez Sagrado M, Conde R, et al. Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients. Diab Res Clin Pract 2009;84:174-178.
6. Matsuzawa Y. Adipocytokines: Emerging therapeutic targets. Curr Atheroscler Rep 2005;7:58-62.
7. Kumada M, Kihara S, Sumitsuji S. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-89.
8. Shimomoura I, Hammer RE, Ikemoto S. Leptin reverses insulin resitance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999;401:73-76.
9. Gnacinska M, Malgorzewicz S, Llysiak W, Sworczak K. The resum profile of adipokines in overweight patients with metabolic syndrome. Pol J Endocrinol 2010 61:36-41.
10. Lee JM, Kim SR, Hong OK, Son HS, Chang SA. The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. J Int Med Res 2009;37:1803-1812.
11. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF. Homesotasis model assessment: Insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-414.
12. Pichard C, Slosman D, Hirschel B, Kyle U. Bioimpedance analysis: An improved method for nutritional follow up. Clin Res 1993;41:53.
13. Mataix J, Mañas M. 1998. Tablas de composición de alimentos españoles ed. Granada: University of Granada.
14. Speakman JR, Stubbs RJ, Mercer JG. Does body mass play a role in the regulation of food intake? Proc Nutr Soc 2002;61:473-487.
15. Frayn KN, Karpe F, Fielding BA, Macdonald IA, Coppack SW. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord 2003;27:875-888.
16. Abdella NA, Mojiminiyi OA, Moussa MA, Zaki M, Al Mohammedi H. Plasma leptin concentration in patients with type 2 diabetes: Relationship to cardiovascular disease risk factors and insulin resistance. Diabet Med 2005:22:278-285.
17. Schoppen S, Riestra P, García-Anguita A, et al. Leptin and adiponectin levels in pubertal children: Relationship with anthropometric variables and body composition. Clin Chem Lab Med. 2010;48:707-711.
18. Salmennienmi U, Zacharova J, Ruotsalainen E, Vauhkonen I, Pihlajamaki J, Kainulainen S. Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy espenditure and cytokines in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 2005;90:4216-4223.
19. Mantzmoros CS, Manson JE, Meigs J, Hu FB. Circulating adiponectin levels are associated with better glycemic control, more favourable lipid profile and rediced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 2005;90:4542-4548.
20. Ohmori R, Momiyama Y, Kato R, et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 2005;46:379-380.
21. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111:932-939.
22. Kunnari A, Ukkola O, Paivansalo M, Kesaniemi YA. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J Clin Endocrinol Metab 2006;91:2755-2760.
23. Axelsson J, Bergsten A, Qureshi AR, et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006;69:596-604.
24. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. 2005. Resistin, an adipokine with potent proinflammatory properties. J Immunol 174:5789-5795.
25. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-2282.
26. Koh SJ, Jang Y, Hyun YJ, et al. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans. Clin Endocrinol (Oxf) 2009;70:238-244.
27. Park JS, Cho MH, Nam JS, et al. Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients. Acta Diabetol 2010;47:113-118.